CD8A and neoplasm: Consistent with the dispensable role of CD8+ T cells in this process, disrupting cDC1-dependent cross-priming of CD8+ T cells using Batf3-deficient hosts did not impair the tumor suppressive effects of NEC immunization (Fig. 4D).